- Home
- Equipment
- north korea
- immune responses
Show results for
Refine by
Applications
- Ativa - Diagnostic Workstation for Pharmacies and Retail Clinics
- Ativa - Diagnostic Workstation for Emergency Departments
- Ativa - Diagnostic Workstation for Primary Care
- Ativa - Diagnostic Workstation for Covid-19
- microbiota for Clinical Studies
- Microbiome Therapeutics for Clinical Trials
- Vaccine for COVID-19
- Solution for Clinical Trials
- Solution for Access to Investigational Medicines
- M2SR - Single Replication Live Virus Vaccine for Influenza
Immune Responses Equipment & Supplies In North Korea
198 equipment items found
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
using precise antibody Fc modifications that tailor the antibody-mediated immune response. Get the optimal response. Tailor immune system response for a desired therapeutic effect using the Effector Function Enhancement and Control Technology’s (EFECT™) library of Fc region modifications. The ...
by:Diasorin based inSALUGGIA, ITALY
DiaSorin strives to improve health-care around the globe through the development of innovative diagnostic solutions that can lead to better patient outcomes and provide economic benefits to the healthcare system. Thanks to its team of dedicated scientists DiaSorin has been able to promptly deliver diagnostic solutions to manage the COVID-19 pandemic ...
Manufactured by:Treos Bio Limited based inLondon, UNITED KINGDOM
At TREOS we discovered that an individual’s HLA genotype is the main determinant of immune responses. This breakthrough led to the development of the PEPI Test (CE Marked) that predicts peptide-specific T cell responses of HLA genotyped individuals. Based on the PEPI Test we have been co-developing with each PolyPEPI™ product a ...
Manufactured by:INOVIO Pharmaceuticals based inPlymouth Meeting, PENNSYLVANIA (USA)
Once inside the cell, the DNA plasmids enable the cell to produce the targeted antigen. The antigen is processed naturally in the cell and triggers the desired T cell and antibody-mediated immune response. Administration with the CELLECTRA device ensures that the DNA medicine is efficiently delivered directly into the body’s cells, where it can go to work ...
Manufactured by:Regeneron Pharmaceuticals Inc. based inTarrytown, NEW YORK (USA)
VelocImmune is our unique technology for producing fully human monoclonal antibodies. VelocImmune creates a multitude of optimized antibody drug candidates efficiently and directly from immunized mice. This approach overcomes the limitations of traditional platforms by rapidly creating fully human antibodies that tightly bind to therapeutic targets and avoid potential ...
by:Vir Biotechnology, Inc. based inSan Francisco, CALIFORNIA (USA)
We have established a robust method for capitalizing on unusually successful immune responses naturally occurring in people who are protected from, or have recovered from, infectious diseases. We identify rare antibodies from survivors that have the potential to treat and prevent rapidly evolving and/or previously untreatable pathogens via direct pathogen ...
Manufactured by:Meissa Vaccines, Inc. based inRedwood City, CALIFORNIA (USA)
The attenuation of a virus to produce a vaccine must balance reducing its virulence while retaining its ability to stimulate an effective immune response, or immunogenicity. Natural RSV infection does not stimulate a robust immune response, and immunity following SARS-CoV-2 infection wanes, so vaccine ...
Manufactured by:Biomex GmbH based inHeidelberg, GERMANY
This was done by collecting plasma from an individual during the evolution of an infection, and the ensuing immunological response. Our seroconversion panels contain defined infection markers and include extensive sample data for comparative analysis. Our SCPs are intended to be used in standard tests by diagnostic manufacturers and researchers during assay development, ...
Manufactured by:NanoEnTek, Inc. based inGuro-gu, SOUTH KOREA
The FREND COVID-19 Neutralization Ab is a point-of-care testing (POCT) which can be used to check whether a patient has developed the immune response to SARS-CoV-2 using human serum or plasma ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
Novavax' saponin-based Matrix-M improves immune responses and enables vaccine dose-sparing. Matrix-M adjuvant is a valuable component of vaccine development, providing multiple immune system enhancements, a well-understood mechanism of action, and robust clinical experience where it was shown to be well tolerated in human studies to ...
Manufactured by:PharmAbcine Inc. based inYuseong-gu, SOUTH KOREA
PMC-309 is an engineered monoclonal antibody that targets the negative immune checkpoint human VISTA (V-domain Ig suppressor of T cell activation). It indirectly promotes T cells' immune responses by inhibiting VISTA-expressing immunosuppressive cells such as MDSCs (Myeloid-Derived Suppressor Cells) which suppress T cell inactivation and ...
Manufactured by:Caprico Biotechnologies, Inc. (CBI) based inNorcross, GEORGIA (US) (USA)
It is also known as Cambridge pathology antigen 1 (CAMPATH-1). Binding of CF-1D12 with CD52 induces a potent complement-mediated cytolytic immune response of matured lymphocytes. It is widely expressed on the surface of thymocytes and mature lymphocytes, on monocytes, dendritic cells, eosinophils and epithelial cells of the epididymis and seminal vesicles but not ...
Distributed by:Labex Canada Inc. based in, ONTARIO (CANADA)
The COVID-19 Vaccine IgG Rapid Test is a lateral flow immunoassay intended for the qualitative detection of antibodies binding to the Receptor Binding Domain (RBD) of the spike protein of the SARS-CoV-2 virus or COVID-19 vaccine in human serum, plasma or whole blood. The kit is intended for use as an aid in identifying individuals with an adaptive immune ...
Manufactured by:Bilthoven Biologicals based inBilthoven, NETHERLANDS
Among other uses, this vaccine is used for the global polio eradication program (GPEI). For IPV vaccine, we use inactivated (dead) polio virus. After vaccination, the inactivated virus triggers an immune response, but can no longer cause the disease ...
Manufactured by:Fresenius SE & Co. KGaA based inBad Homburg v.d.H., GERMANY
FX CorALs Helixone hydro membrane forms a hydrolayer on the inner membrane surface for reduced protein adsorption, resulting in a membrane with low immune response and high selective permeability. 26'27>28-29 Focal points of FX CorAL's development were clinical performance and hemocompatibility, because these two factors belong together in patient centred ...
Manufactured by:PeptaNova GmbH based inSandhausen, GERMANY
Phebestin can be used in various biochemical assays where selective inhibition of APN is desired, making it integral for research in cellular signaling and immune response. Its specific inhibitory action provides valuable insights into enzymatic processes involving aminopeptidases, positioning Phebestin as an important tool in the study of enzyme functions and ...
Manufactured by:Immunadd, Inc. based inTaipei City, TAIWAN
IA-05 is a truncated QS-21 analogue with improved tolerability, stability, and long-term immune responses in combination of various antigens. IA05 is expected to lead novel utilities in development of immunotherapies and therapeutic ...
Manufactured by:Transgene based inIllkirch-Graffenstaden, FRANCE
Two specific “weapons” have been integrated into the Vaccinia viral DNA: an anti-CTLA4 antibody, which was developed by BioInvent, and the cytokine GM-CSF, which triggers the body’s immune ...
by:Kephera Diagnostics, LLC based inFramingham, MASSACHUSETTS (USA)
COVI-QUANT™ is an ELISA test available through Kephera’s CLIA laboratory. Studies show that not all individuals develop a strong immune response after COVID-19 infection or vaccination, especially those who have an immunocompromising condition due to disease, medical treatment, organ transplantation, age, or other causes. These individuals may ...
Manufactured by:Treos Bio Limited based inLondon, UNITED KINGDOM
Our Peptide Library (PEPI Panel) currently contains 3,286 proprietary, immunogenic peptide fragments from 184 tumor antigens associated with 19 cancer indications that induce immune responses in the largest subpopulation of subjects, based on HLA genotype (both class I and II) of 16,000 subjects. PEPI Panel approach guides selection of 12 individual peptides ...